# Wolfgang Köenig

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wolfgang-koenig/

## Facts

| Field | Value |
| --- | --- |
| Citations | 133,455 |
| Field | Adipokines, Inflammation, and Metabolic Diseases |
| h-index | 149 |
| i10-index | 843 |
| Last Known Institution | Zimmer Biomet (Netherlands) |
| OpenAlex ID | https://openalex.org/A5028480812 |
| ORCID iD | https://orcid.org/0000-0002-2064-9603 |
| Works | 1,552 |

## Researcher papers

Showing 12 of 15.

- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice](https://scholariq.org/papers/2021-esc-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice/)
- [Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction](https://scholariq.org/papers/efficacy-and-safety-of-low-dose-colchicine-after-myocardial-infarction/)
- [Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy](https://scholariq.org/papers/clinical-features-and-outcomes-of-takotsubo-stress-cardiomyopathy/)
- [Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol](https://scholariq.org/papers/two-phase-3-trials-of-inclisiran-in-patients-with-elevated-ldl-cholesterol/)
- [Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-interleukin-1-inhibition-with-canakinumab-on-incident-lung-cancer-in/)
- [World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions](https://scholariq.org/papers/world-health-organization-cardiovascular-disease-risk-charts-revised-models-to/)
- [Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk](https://scholariq.org/papers/effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)
- [New loci associated with kidney function and chronic kidney disease](https://scholariq.org/papers/new-loci-associated-with-kidney-function-and-chronic-kidney-disease/)
- [Mendelian randomization of blood lipids for coronary heart disease](https://scholariq.org/papers/mendelian-randomization-of-blood-lipids-for-coronary-heart-disease/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)

## Researcher topics

- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [High-Energy Particle Collisions Research](https://scholariq.org/topics/high-energy-particle-collisions-research/)
- [Particle physics theoretical and experimental studies](https://scholariq.org/topics/particle-physics-theoretical-and-experimental-studies/)

## Researcher university

- [Zimmer Biomet (Netherlands)](https://scholariq.org/institutions/zimmer-biomet-netherlands/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.